Sapigen Biologix, Technology Development Board collaborate for malaria, COVID nasal vaccine Ruchika Sharma28 March 2022 11:00 AM ISTNew Delhi: The Technology Development Board (TDB) of the Union Ministry of Science and Technology and Sapigen Biologix Private Limited, Hyderabad on...
2 dose Hepatitis B vaccine not significantly associated with increased MI risk compared to 3 dose vaccine: JAMA Medical Dialogues Editorial Team28 March 2022 9:00 AM ISTWhen comparing the hepatitis B vaccination with a cytosine phosphoguanine adjuvant (HepB-CpG) vaccination to the HepB-alum vaccine, the statistical...
Pfizer gets USFDA Breakthrough Therapy Designation for RSV Vaccine Ruchika Sharma26 March 2022 9:45 AM ISTNew York: Pfizer Inc. has announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, has received...
SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
Infant COVID vaccine succeeded in trial: Moderna Ruchika Sharma24 March 2022 10:00 AM ISTCambridge: Moderna, Inc. has recently announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine (mRNA-1273) in...
Immunocompromised COVID-19 patient successfully treated with vaccine: Case report Medha Baranwal23 March 2022 7:21 PM ISTUK: A recent case study, published in the Journal of Clinical Immunology, describes the case of a man in the UK who tested positive for coronavirus...
Decrease gap between two doses of Covishield to 8-16 weeks, suggests panel MD Bureau21 March 2022 1:00 PM ISTThe government had on May 13, 2021, extended the gap between the first and second doses of the Covishield vaccine from 6-8 weeks to 12-16 weeks, based...
Wockhardt , Serum Life Sciences collaborate for manufacturing multiple vaccines MD Bureau21 March 2022 12:54 PM ISTThis collaboration between a subsidiary of Wockhardt and Serum Life Sciences UK will help create considerable number of employment opportunities...
Moderna submits amendment to USFDA for its COVID-19 vaccine booster dose MD Bureau20 March 2022 2:15 PM ISTThe U.S. FDA approved the Biologics License Application (BLA) for SPIKEVAX (COVID-19 Vaccine, mRNA) to prevent COVID-19 in individuals 18 years of age...
Is short-term follow-up suitable clinical approach for MRI-detected adenopathy after COVID-19 vaccination? Medha Baranwal18 March 2022 9:00 AM ISTUSA: Adenopathy after COVID-19 vaccination is a frequent event; short-term follow-up is a suitable clinical approach, except in patients with current...
NIH Launches Clinical Trial of Three mRNA HIV Vaccines MD Bureau17 March 2022 4:42 PM IST"Finding an HIV vaccine has proven to be a daunting scientific challenge," said Anthony S. Fauci, M.D. NIAID director. "With the success of safe and...
Delhi: AIIMS to start clinical trial of intranasal COVID-19 vaccine from Friday, as per sources Medical Dialogues Bureau11 March 2022 11:57 AM ISTNew Delhi: All India Institute of Medical Sciences (AIIMS) Delhi will start the clinical trials of Bharat Biotech's intranasal booster dose against...
